Webinar presenters Pranil K. Chandra, DO, Senior Vice President, Chief Genomics Officer PathGroup, and Nayan J. Sarma, PhD, HCLD/CC (ABB), Associate Director of Molecular Oncology PathGroup, and Jeff Gregg, MD, Vice President Medical Affairs, Biofidelity, Professor of Pathology and Laboratory Medicine, University of Nevada School of Medicine, address the gaps and limitations of CGP by using innovative simplified genomic profiling solutions that work for challenging samples not analyzable by CGP. Aspyre is a breakthrough technology that allows detection of DNA and RNA based biomarkers for all 11 guideline-recommended genes in a rapid turnaround time with exceptional sensitivity.
This on-demand webinar originally broadcast January 22, 2025.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Biofidelity.